PROSTATE STEM CELL ANTIGEN

Application 2607/KOLNP/2005 published 2006-10-20, filed 2005-12-15
PSCA and its encoded protein, and variants thereof, are described wherein PSCA exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, PSCA provides a diagnostic, prognostic, propylactic and/or therapeutic target for cancer. The PSCA gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with PSCA can be used in active or passive immunization. (FIG. Nil)

Applicant

AGENSYS, INC.,
1545 17TH STREET, SANTA MONICA, CA 90404, USA.

Inventor

JAKOBOVITS AYA GE WANGMAO RAITANO ARTHUR B CHALLITA-EID PIA M

International Info

Classification: C12N
Publication Number: WO 05/014780
Application Date: 2004-05-28

Priority Information

60/475,064 USA 2003-05-30